China Single Cell Sequencing Market (2025-2030)
The China Single Cell Sequencing Market was valued at $119.6 Million in 2025 and projected to reach to $219.1 Million by 2030, representing a compound annual growth rate of 12.9%. China's single cell sequencing market is poised for substantial growth as the nation strengthens its position in precision medicine and genomic research.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
China Single Cell Sequencing Market Trends and Insights
- This growth trajectory reflects China's increasing investment in genomic research infrastructure and rising adoption of advanced sequencing technologies across academic and clinical institutions.
- China is emerging as a key hub for single cell analysis applications in cancer research, immunology, and developmental biology, driven by government support for precision medicine initiatives and expanding biopharmaceutical R&D capabilities. The market in China is characterized by accelerating demand from research institutions, hospitals, and biotech companies seeking to unlock cellular heterogeneity insights.
- China's competitive advantage in manufacturing and cost-effective sequencing solutions positions the country as both a significant consumer and producer of single cell sequencing platforms.
- Between 2025 and 2030, China is expected to capture increasing market share within Asia Pacific, supported by growing collaborations between domestic and international genomics firms and rising venture capital investment in life sciences startups..
Key Market Statistics
- CAGR (2025-2030) 12.9% CAGR
- Market Size, 2025 ~USD 119.6 Million
- Forecast, 2030 ~USD 219.1 Million
- Country China
China Single Cell Sequencing Market Overview
Rapid Market Expansion :
China's single cell sequencing market is growing at 12.9% CAGR, outpacing the global rate of 12.2%, driven by substantial government funding for genomic research and biotechnology initiatives.
Strategic Research Infrastructure :
Major Chinese research institutions and universities are investing heavily in single cell analysis capabilities, positioning China as a leading hub for genomic innovation in Asia-Pacific.
Clinical Adoption Acceleration :
Chinese hospitals and diagnostic centers are increasingly integrating single cell sequencing into cancer research, immunology studies, and personalized medicine applications.
Market Valuation Growth :
The market is projected to nearly double from $119.6 million in 2025 to $219.1 million by 2030, reflecting strong demand across academic, clinical, and pharmaceutical sectors.
China Single Cell Sequencing Market Dynamics
- Government support through funding initiatives and regulatory frameworks is accelerating technology adoption across research institutions and clinical laboratories.
- The expanding pharmaceutical and biotechnology sectors are driving demand for advanced sequencing capabilities to support drug discovery and development. Key growth drivers include increasing collaboration between Chinese institutions and international research organizations, rising prevalence of cancer and genetic disorders requiring advanced diagnostics, and growing investment in single cell analysis platforms.
- By 2030, China is expected to become a major market for single cell sequencing technologies, with significant opportunities for both domestic and international vendors serving the region's rapidly evolving research and clinical landscape..
Related Ecosystem
Advanced Genetic Sequencing
- Polymerase Chain Reaction (PCR)
- Reagents
- Assay Kits
- Bioinformatics
- Flow Cytometry
- Thermo Fisher Scientific Inc.
- Illumina, Inc.
- Agilent Technologies, Inc.
- Qiagen N.V.
- Danaher Corporation
Biotechnology
- Reagents
- Polymerase Chain Reaction (PCR)
- Stem Cells
- Assay Kits
- Flow Cytometers
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
Key Takeaways
- China's single cell sequencing market is valued at $119.6 million in 2025 and is forecast to grow to $219.1 million by 2030, representing a 12.9% CAGR.
- China is rapidly establishing itself as a major genomics hub, with government-backed precision medicine initiatives driving adoption of single cell sequencing technologies.
- Research institutions and biotech companies in China are increasingly leveraging single cell analysis for cancer, immunology, and developmental biology applications.
- China's manufacturing capabilities and cost-competitive solutions position the country as both a significant market and production center within the Asia Pacific region.
Single Cell Sequencing Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | SERVICES (Offering) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 12.2% from 2025 to 2030 |
| Largest Segment | PRODUCTS (Offering) |
| Market Size Base Year (Billions) | ~USD 1.95 (2025) |
| Revenue Forecast (Billions) | ~USD 3.46 (2030) |
| Segments Covered | Offering, Type, End User, Sequencing Type, Application, Workflow |
China Single Cell Sequencing Market Report Segmentation
6 segment dimensions are covered across the global market.
By Offering
- Products
- Services
By Type
- Basic & Translational Research
- Cancer Research
- Cell Sorters
- Consumables
- Data Analysis & Bioinformatics Services
- Data Storage & Management Software
- Drug Discovery & Development
- Instruments
- Lcm Instruments
- Library Preparation Services
- Microbiology & Infectious Diseases
- Microfluidic Instruments
- Neurology & Brain Research
- Organ Development & Regenerative Medicine
- Other Pre-Sequencing Instruments
- Pcr Instruments
- Pre-Sequencing Instruments
- Pre-Sequencing Reagents & Kits
- Pre-Sequencing Services
- Sample Preparation, Single-Cell Isolation, And Enrichment Services
- Sequencing Platforms
- Sequencing Reagents & Kits
- Sequencing Services
- Software
- Software Tools
- Stem Cell & Developmental Biology
By End User
- Academic & Research Institutes
- Biotechnology & Pharmaceutical Companies
- Cros
- Hospitals & Clinical Laboratories
- Pharmaceutical & Biopharmaceutical Companies
By Sequencing Type
- Other Single-Cell Sequencing Types
- Scatac-Seq
- Scdna-Seq
- Scrna-Seq
By Application
- Diagnostic & Clinical Applications
- Research Applications
By Workflow
- Data Analysis & Interpretation
- Pre-Sequencing
- Sequencing
CHINA: SINGLE-CELL SEQUENCING PRODUCTS MARKET, BY END USER, 2023–2030
| Segment | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| ACADEMIC & RESEARCH INSTITUTES | 48.3 | 49.3 | 50.9 | 54.7 | 60.7 | 68.9 | 79.9 | 94.1 | 13.1 |
| CROS | 10.3 | 10.3 | 10.5 | 11.2 | 12.2 | 13.7 | 15.7 | 18.2 | 11.6 |
| HOSPITALS & CLINICAL LABORATORIES | 21.9 | 22.2 | 22.7 | 24.2 | 26.6 | 30 | 34.5 | 40.3 | 12.1 |
| PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES | 33.5 | 34.2 | 35.5 | 38.2 | 42.5 | 48.5 | 56.3 | 66.5 | 13.4 |
| TOTAL | 114 | 116 | 119.6 | 128.3 | 142 | 161.1 | 186.3 | 219.1 | 12.9 |
CHINA: SINGLE-CELL SEQUENCING SERVICES MARKET, BY END USER, 2023–2030
| Segment | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| ACADEMIC & RESEARCH INSTITUTES | 13.9 | 16.1 | 17.7 | 20.1 | 23.2 | 27.4 | 33.1 | 40.8 | 18.2 |
| BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES | 12 | 13.9 | 15.4 | 17.6 | 20.5 | 24.3 | 29.6 | 36.8 | 18.9 |
| HOSPITALS & CLINICAL LABORATORIES | 7.1 | 8.1 | 8.7 | 9.7 | 11 | 12.7 | 15.1 | 18.3 | 15.9 |
| TOTAL | 33 | 38.1 | 41.8 | 47.4 | 54.7 | 64.4 | 77.7 | 95.9 | 18 |
Target Audience
- Sequencing Technology Vendors : Equipment and platform manufacturers need China-specific market data to develop localized go-to-market strategies, pricing models, and distribution partnerships in this rapidly expanding market.
- Pharmaceutical & Biotech Companies : Drug developers and biotech firms require insights into China's single cell sequencing adoption to optimize R&D investments, identify collaboration opportunities, and accelerate product development timelines.
- Research Institutions & Universities : Academic centers need market intelligence to benchmark their genomic capabilities, identify funding opportunities, and understand technology trends shaping China's research landscape.
- Clinical Diagnostics Providers : Hospital networks and diagnostic laboratories require data on clinical adoption rates and reimbursement trends to justify investments in single cell sequencing infrastructure.
- Investment & Strategy Consultants : Private equity firms, venture capitalists, and management consultants need comprehensive China market analysis to evaluate investment opportunities and advise clients on market entry strategies.
Reasons to Buy this Report
- China-Specific Market Sizing : Obtain precise valuation data for China's single cell sequencing market with detailed 2025-2030 forecasts, enabling accurate business planning and investment decisions tailored to this high-growth region.
- Competitive Landscape Intelligence : Understand key players, market share distribution, and competitive dynamics specific to China's genomic research sector to identify partnership and expansion opportunities.
- Regulatory & Infrastructure Insights : Gain detailed knowledge of China's regulatory environment, research funding mechanisms, and institutional adoption patterns critical for market entry and growth strategies.
- Segment & Application Analysis : Access granular data on single cell sequencing applications across Chinese academic institutions, hospitals, and pharmaceutical companies to target high-potential customer segments.
- Growth Driver Identification : Identify and quantify specific factors driving China's 12.9% CAGR, including government initiatives, clinical adoption trends, and technology investments for strategic planning.
Frequently asked questions
What is the current market size of single cell sequencing in China?
China's single cell sequencing market is valued at $119.6 million in 2025 and is projected to reach $219.1 million by 2030.
What is the expected growth rate for China's single cell sequencing market?
China's single cell sequencing market is expected to grow at a compound annual growth rate (CAGR) of 12.9% from 2025 to 2030.
Which applications are driving single cell sequencing adoption in China?
Cancer research, immunology, and developmental biology are the primary applications driving single cell sequencing adoption in China, supported by government precision medicine initiatives.
What factors are contributing to market growth in China?
Key growth factors include increased government investment in genomic research, rising adoption by research institutions and biotech companies, expanding biopharmaceutical R&D, and China's competitive manufacturing advantages.
How does China's market compare to the global single cell sequencing market?
China's 12.9% CAGR slightly exceeds the global CAGR of 12.2%, indicating that China is growing faster than the global average and gaining market share within Asia Pacific.
RESEARCH METHODOLOGY
This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global single-cell sequencing market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the single cell sequencing market. The secondary sources used for this study The secondary sources used for this study include the World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), the International Clinical Cytometry Society (ICCS), the International Society for Advancement of Cytometry (ISAC), the National Institutes of Health (NIH), the Organisation for Economic Co-operation and Development (OECD), and the Society for Laboratory Automation and Screening (SLAS); Corporate and Regulatory Filings, Annual Reports, Sec Filings, Investor Presentations, and Financial Statements; Business Magazines & Research Journals; Press Releases, MarketsandMarkets Analysis. These sources also obtained key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
Extensive primary research was conducted after acquiring basic knowledge about the global single-cell sequencing market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (personnel from, pharmaceutical & and biotechnology companies, hospitals & diagnostic laboratories, academic & research institutes, and contract research organization) and supply side (C-level and D-level executives, product managers, and marketing and sales managers of key manufacturers, distributors, and channel partners, among others, across six major regions—North America, Europe, the Asia Pacific, Latin America, Middle East, and Africa. Approximately 70% of primary interviews were conducted with supply-side representatives, while demand-side participants accounted for the remaining share. This preliminary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the single-cell sequencing market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Single Cell Sequencing Market : Top-Down and Bottom-Up Approach
Data Triangulation
After arriving at the overall market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable.
Market Definition
Single-cell sequencing (SCS) is a genomic technology that allows researchers to study the genetic material of individual cells. Unlike traditional sequencing methods that analyze bulk cell populations, single-cell sequencing helps identify differences between individual cells, providing a clearer understanding of cell functions, disease mechanisms, and treatment responses. The scope of the single-cell sequencing market includes a wide range of products and services used across the entire single-cell workflow. This covers pre-sequencing instruments and consumables (such as cell isolation tools and library preparation kits), sequencing instruments and consumables, and software for analyzing single-cell data. The market also includes services provided by third parties across pre-sequencing, sequencing, and data analysis stages. The market also studies various sequencing types, including single-cell RNA sequencing (scRNA-seq), single-cell DNA sequencing (scDNA-seq), and single-cell ATAC sequencing (scATAC-seq), among others. These technologies are widely used in basic and translational research, drug discovery, and clinical applications, especially in cancer, neurological, and infectious diseases. End users of these solutions studied in the report include academic and research institutions, pharmaceutical and biotechnology companies, hospitals and diagnostic labs, and contract research organizations (CROs).
Stakeholders
- Academic & Research Institutes
- Single-cell Sequencing Assay & Reagent Manufacturers, Vendors, and Distributors
- Contract Research Organizations (CROs)
- Single-cell Sequencing Service & Software Providers
- Diagnostics Companies
- Market Research & Consulting Firms
- Pharmaceutical & Biotechnology Companies
- Regulatory Agencies
- Venture Capitalists
- Government organizations
- Contract Development & Manufacturing Organizations (CDMOs)
- Hospitals and Diagnostic Laboratories
Report Objectives
- To define, describe, and forecast the global single-cell sequencing market based on offering, product type, product workflow, product end user, service type, service end user, sequencing type, application, and region
- To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
- To strategically analyze micro-markets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to six central regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
- To profile the key players in the global single-cell sequencing market and comprehensively analyze their core competencies and market shares
- To track and analyze competitive developments such as acquisitions, product launches & approvals, expansions, agreements, partnerships, and collaborations in the single-cell sequencing market
- To benchmark players in the single-cell sequencing market using the “Company Evaluation Matrix” framework, which analyzes market players based on various parameters, including product portfolio, geographic reach, and market share
Available Customizations
With the given market data, MarketsandMarkets offers customizations to meet the company’s needs. The following customization options are available for the report:
Geographical Analysis
- Further breakdown of the Rest of Europe’s single-cell sequencing market, by country
- Further breakdown of the Rest of Asia Pacific’s single-cell sequencing market, by country
- Further breakdown of the Rest of Latin America’s single-cell sequencing market, by country
- Further breakdown of the Rest of the Middle East’s single-cell sequencing market, by country
Company Information
- Detailed analysis and profiling of additional market players (up to five)
Segment Analysis
- Further breakdown of the other technologies into subsegments
- Cross-segment analysis
Get the Full Single Cell Sequencing Market Report
Full forecast, segment splits, and company analysis for all Single Cell Sequencing Market.
- Rest Of Asia Pacific Single Cell Sequencing Market
- Rest Of Latin America Single Cell Sequencing Market
- Ksa Single Cell Sequencing Market
- Other GCC Countries Single Cell Sequencing Market
- UAE Single Cell Sequencing Market
- US Single Cell Sequencing Market
- Canada Single Cell Sequencing Market
- UK Single Cell Sequencing Market
- Germany Single Cell Sequencing Market
- France Single Cell Sequencing Market
- Italy Single Cell Sequencing Market
- Spain Single Cell Sequencing Market
- Japan Single Cell Sequencing Market
- India Single Cell Sequencing Market
- South Korea Single Cell Sequencing Market
- Australia Single Cell Sequencing Market
- Brazil Single Cell Sequencing Market
- Mexico Single Cell Sequencing Market
- Rest Of Europe Single Cell Sequencing Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
